Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on June 4, 2025

Telos Corporation Awarded $14M Contract with the Defense Information Systems Agency

Telos Corporation Awarded $14M Contract with the Defense Information Systems Agency

ASHBURN, Va., June 04, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it was awarded the Defense …

Centurion Service Group to auction all assets following the closure of Crozer-Chester Medical Center in Upland, PA; Taylor Hospital in Ridley Park, PA; and Springfield Hospital in Springfield, PA

Centurion Service Group to auction all assets following the closure of Crozer-Chester Medical Center in Upland, PA; Taylor Hospital in Ridley Park, PA; and Springfield Hospital in Springfield, PA

Franklin Park, Illinois, June 04, 2025 (GLOBE NEWSWIRE) -- Centurion Service Group, an industry-leading medical equipment life-cycle company, has been selected to auction all medical and non-medical assets of Crozer-Chester Medical Center in Upland, PA; …

Aligned Data Centers Debuts Advanced Cooling Lab to Further Accelerate Cooling Technology Innovation for Next-Gen GPUs

Aligned Data Centers Debuts Advanced Cooling Lab to Further Accelerate Cooling Technology Innovation for Next-Gen GPUs

DALLAS , June 04, 2025 (GLOBE NEWSWIRE) -- Aligned Data Centers, a leading technology infrastructure company offering innovative, sustainable and adaptive Scale Data Centers and Build-to-Scale solutions for global hyperscale, AI / HPC, and enterprise …

Biodexa Announces Recruitment of First Patient  in Phase 2 Study of Tolimidone in Type 1 Diabetes

Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes

June 4, 2025 Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of …

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development

PITTSBURGH, June 04, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced that it …

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

Glucotrack to present on next-generation continuous blood glucose monitoring technology in Innovation Hub Poster presentation to highlight insights on safety and performance data from direct blood glucose measurement technology RUTHERFORD, N.J., June 04, …

Veea and StarGroup Join Forces to Transform Mexico’s Digital Divide with Smart Connectivity and Entertainment Solutions

Veea and StarGroup Join Forces to Transform Mexico’s Digital Divide with Smart Connectivity and Entertainment Solutions

NEW YORK and MEXICO CITY, June 04, 2025 (GLOBE NEWSWIRE) -- Veea Inc. (NASDAQ: VEEA), a global innovator in edge computing and AI-driven platforms, and StarGroup, one of Mexico’s most dynamic and visionary telecommunications and entertainment providers, …

ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance

ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance

LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a specialty pharmaceutical company, today announced that it remains fully operational and is actively working to complete its overdue annual and quarterly financial …

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to capture commercial potential in the $15 billion animal health market Evaluation of AZD5658 expands Conduit’s …

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

- Gadolinium-160 is a critical precursor isotope for producing Terbium-161, an emerging medical isotope with significant potential in targeted radiotherapies. - Supply agreement is for four years’ supply of enriched Gd-160, commencing in 2026, with an …

ClarityCut AI Unveils New Creative Engine for Branded Video Production

ClarityCut AI Unveils New Creative Engine for Branded Video Production

SEATTLE, June 04, 2025 (GLOBE NEWSWIRE) -- CLEANZONE HVAC LLC has introduced the next evolution of video creation with the latest update to its AI-powered platform, ClarityCut AI. Designed for content creators, educators, and digital marketers, ClarityCut …

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

MIRAMAR, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by …

FOXO TECHNOLOGIES INC. COMPLETES EQUITY FUNDING AGREEMENT

FOXO TECHNOLOGIES INC. COMPLETES EQUITY FUNDING AGREEMENT

WEST PALM BEACH, FLORIDA, June 04, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that it has executed an agreement to issue 1,650 of its Series A Cumulative Convertible Redeemable Preferred …

Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM)

Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM)

Designation Supported by CLOVER WaM Phase 2 Study Data Which Reported an 83.6% Overall Response Rate (ORR) Seeking Guidance from EMA to Determine if CLOVER WaM Phase 2 Data Meets Criteria to Apply for Fast-Track, Conditional Marketing Authorization, Answer …

Salsify Launches FeedbackIQ to Streamline GDSN with AI

Salsify Launches FeedbackIQ to Streamline GDSN with AI

BOSTON, June 04, 2025 (GLOBE NEWSWIRE) -- Salsify, the Product Experience Management (PXM) platform empowering brand manufacturers, distributors, and retailers to win on the digital shelf, today announced a significant enhancement to its Global Data …

Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors

Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors

Phase 11 First-In-Human study designed to assess safety, tolerability, right dose for Phase 2 and early signs of efficacy of 177Lu-RAD202 in individuals with advanced HER2-positive solid tumors Previous clinical proof-of concept data2 for targeting HER-2 …

Melissa’s Azure Integration of SSIS Components Extends Data Quality to the Cloud

Melissa’s Azure Integration of SSIS Components Extends Data Quality to the Cloud

RANCHO SANTA MARGARITA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- As more enterprises migrate to the cloud in pursuit of scalability, speed, and simplified infrastructure, data quality often remains a bottleneck or development challenge. In response, …

Elicio Therapeutics Secures $10 Million in Financing

Elicio Therapeutics Secures $10 Million in Financing

Funding expected to support operations into Q1 2026. Anticipated AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025. BOSTON, June 04, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage …

Daré Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market Daré’s DARE to PLAY Sildenafil Cream

Daré Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market Daré’s DARE to PLAY Sildenafil Cream

Collaboration will leverage Rosy Wellness’ extensive reach and community of over 250,000 women Rosy Wellness is a multi-award winning app recommended by 8,000+ healthcare professionals Daré expects to start recording revenue in the 4th quarter this year …

Repeat: Rocket Doctor, a Treatment.com AI company, Joins Larta Institute’s 2025 Heal.LA Accelerator Cohort to Expand Access to Virtual Care

Repeat: Rocket Doctor, a Treatment.com AI company, Joins Larta Institute’s 2025 Heal.LA Accelerator Cohort to Expand Access to Virtual Care

One of 15 companies selected across critical areas including chronic disease, women’s health, and mental health. Program provides mentorship, regulatory guidance, and funding access to help scale solutions that improve care access and equity. Rocket Doctor …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service